Profound Medical Corp. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Profound Medical Corp. on February 5, 2026. The filing discloses a material event under Item 7.01 (Regulation FD Disclosure) regarding a milestone achievement by a specialist hospital utilizing the Company's technology.
Key Financial Metrics
The filing text does not provide specific financial data such as revenue, profit, cash flow, margins, debt, or liquidity figures. This report focuses solely on a non-financial operational milestone.
Material Changes and Operational Milestone
The primary disclosure is that the PRO FAMILIA Specialist Hospital in Rzeszów, Poland, has completed its 500th Sonalleve® Procedure. This milestone highlights the adoption and utilization of the Company's Sonalleve MR-guided focused ultrasound system in international markets.
Guidance, Outlook, and Risks
The filing does not contain updated financial guidance, management commentary on future outlook, or specific risk factors beyond the standard legal disclaimers. The press release associated with this filing is furnished as Exhibit 99.1 and is explicitly not deemed "filed" for purposes of Section 18 of the Exchange Act.
Investor Verification Checklist
- Verify the full text of the press release (Exhibit 99.1) for additional context on the 500th procedure milestone.
- Confirm the commercial relationship and revenue recognition status with PRO FAMILIA Specialist Hospital.
- Review subsequent filings for any financial impact resulting from this operational milestone.